{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T07:17:43Z","timestamp":1794035863910,"version":"4.8.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique &amp; Fertilit\u00e9"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.gyobfe.2013.03.003","type":"journal-article","created":{"date-parts":[[2013,5,3]],"date-time":"2013-05-03T18:05:41Z","timestamp":1367604341000},"page":"305-313","source":"Crossref","is-referenced-by-count":9,"title":["Pr\u00e9valence des g\u00e9notypes d\u2019HPV chez les femmes en France\u00a0: implications pour le d\u00e9pistage et la vaccination"],"prefix":"10.1016","volume":"41","author":[{"given":"J.","family":"Monsonego","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Zerat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Syrj\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C.","family":"Zerat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.S.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Halfon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gyobfe.2013.03.003_bib0005","series-title":"GLOBOCAN 2008, cancer incidence and mortality worldwide: IARC Cancer Base No. 10","author":"Ferlay","year":"2010"},{"key":"10.1016\/j.gyobfe.2013.03.003_bib0010","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"De Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.gyobfe.2013.03.003_bib0015","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1016\/j.ejca.2009.07.019","article-title":"HPV infection in Europe","volume":"45","author":"De Vuyst","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.gyobfe.2013.03.003_bib0020","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","article-title":"Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update","volume":"121","author":"Smith","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.gyobfe.2013.03.003_bib0025","author":"Institut national du cancer"},{"key":"10.1016\/j.gyobfe.2013.03.003_bib0030","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1016\/j.vaccine.2012.06.013","article-title":"Prevalence of type-specific human papillomavirus infection among women in France: implications for screening, vaccination, and a future generation of multivalent HPV vaccines","volume":"30","author":"Monsonego","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.gyobfe.2013.03.003_bib0035","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1054\/bjoc.2001.1845","article-title":"Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932\u00a0women","volume":"84","author":"Clavel","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.gyobfe.2013.03.003_bib0040","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/IGC.0b013e31821dd3b2","article-title":"Prevalence of human papillomavirus infection in women in Portugal: the CLEOPATRE Portugal study","volume":"21","author":"Pista","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.gyobfe.2013.03.003_bib0045","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.297.8.813","article-title":"Prevalence of HPV infection among females in the United States","volume":"297","author":"Dunne","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.gyobfe.2013.03.003_bib0050","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1002\/jmv.21910","article-title":"Prevalence of low-risk and high-risk types of human papillomavirus and other risk factors for HPV infection in Germany within different age groups in women up to 30\u00a0years of age: an epidemiological observational study","volume":"82","author":"Iftner","year":"2010","journal-title":"J Med Virol"},{"key":"10.1016\/j.gyobfe.2013.03.003_bib0055","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1002\/ijc.23712","article-title":"Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark","volume":"123","author":"Kjaer","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.gyobfe.2013.03.003_bib0060","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jadohealth.2008.07.009","article-title":"Age-specific prevalence of infection with human papillomavirus in females: a global review","volume":"43","author":"Smith","year":"2008","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.gyobfe.2013.03.003_bib0065","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jadohealth.2008.07.009","article-title":"Age-specific prevalence of human papillomavirus infection in females: a global review","volume":"43","author":"Smith","year":"2008","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.gyobfe.2013.03.003_bib0070","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/sj.bjc.6604162","article-title":"Age-dependent prevalence of 14\u00a0high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening","volume":"98","author":"Coup\u00e9","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.gyobfe.2013.03.003_bib0075","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1473-3099(07)70158-5","article-title":"Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis","volume":"7","author":"De Sanjos\u00e9","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.gyobfe.2013.03.003_bib0080","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1158\/1055-9965.EPI-08-0180","article-title":"Prevalence of genital human papilloma virus infection and genotypes among young women in Sicily, South Italy","volume":"17","author":"Ammatuna","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.gyobfe.2013.03.003_bib0085","doi-asserted-by":"crossref","first-page":"696","DOI":"10.4161\/hv.5.10.9515","article-title":"Evaluation of quadrivalent HPV 6\/11\/16\/18\u00a0vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection","volume":"5","author":"Olsson","year":"2009","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.gyobfe.2013.03.003_bib0090","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2165\/10898580-000000000-00000","article-title":"Human papillomavirus vaccines: current status and future prospects","volume":"70","author":"Garland","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.gyobfe.2013.03.003_bib0095","doi-asserted-by":"crossref","first-page":"e1401","DOI":"10.1136\/bmj.e1401","article-title":"Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data","volume":"344","author":"Joura","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.gyobfe.2013.03.003_bib0100","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ijc.25726","article-title":"Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE study","volume":"129","author":"Monsonego","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.gyobfe.2013.03.003_bib0105","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1093\/jnci\/djp392","article-title":"A new generation of studies of human papillomavirus DNA testing in cervical cancer screening","volume":"101","author":"Franco","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.gyobfe.2013.03.003_bib0110","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1086\/597308","article-title":"Human papillomavirus (HPV) vaccines: limited cross-protection against additional HPV types","volume":"199","author":"Herrero","year":"2009","journal-title":"J Infect Dis"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique &amp; Fertilit\u00e9"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297958913000878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297958913000878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T11:14:45Z","timestamp":1563016485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297958913000878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S1297958913000878"],"URL":"https:\/\/doi.org\/10.1016\/j.gyobfe.2013.03.003","relation":{},"ISSN":["1297-9589"],"issn-type":[{"value":"1297-9589","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}